Antitumor activity of Tigerinin-1: Necroptosis mediates toxicity in A549 cells
Tigerinins are antimicrobial peptides (AMPs) derived from the skin secretions of the Indian bullfrog Hoplobatrachus tigerinus. Tigerinin-1 (FCTMIPIPRCY-Am) peptide was synthesized by solid-phase Fmoc chemistry and investigated its antitumor activities. Tigerinin-1 was cytotoxic to human cancer cells...
Saved in:
Published in | Biochimica et biophysica acta. General subjects Vol. 1866; no. 9; p. 130182 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Tigerinins are antimicrobial peptides (AMPs) derived from the skin secretions of the Indian bullfrog Hoplobatrachus tigerinus.
Tigerinin-1 (FCTMIPIPRCY-Am) peptide was synthesized by solid-phase Fmoc chemistry and investigated its antitumor activities.
Tigerinin-1 was cytotoxic to human cancer cells. It causes necrosis by damaging the cell membrane and loss of lysosome integrity. Tigerinin-1triggers the expression of necroptosis pathway proteins. It generates reactive oxygen species (ROS) and induces oxidative stress-mediated genotoxicity. Tigerinin-1 inhibits cancer cell proliferation, reduces neovascularization, and down-regulates the vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor 2 (VEGFR2), and fibroblast growth factor (FGF) genes.
Tigerinin-1 exhibited its potent antitumor properties in this study.
Tigerinin-1 can be beneficial for developing novel therapeutics for cancer.
[Display omitted]
•Tigerinin-1 peptide synthesized by solid-phase Fmoc chemistry.•Tigerinin-1 is cytotoxic to human cancer cells.•Tigerinin-1 triggers the expression of necroptosis proteins.•Tigerinin-1-induced necroptosis leads to oxidative stress-mediated genotoxicity.•Tigerinin-1 has anti-angiogenic nature. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0304-4165 1872-8006 1872-8006 |
DOI: | 10.1016/j.bbagen.2022.130182 |